Posted June 24, 2011 on Domain-B GlaxoSmithKline Plc (GSK) and SB Pharmco Puerto Rico Inc yesterday agreed to pay $40.75 million to 37 US states and the District of Columbia to settle allegations on selling substandard antidepressants and other medicines produced at its former Puerto Rico factory in the early 2000′s. The 37 states had Full Article…
Search LawsuitInformation.org
Viewing 1 to 10 of 11 items
Doctors Warning: Taking Paxil During Pregnancy Gives 50% Chance of Babies Suffering from Birth Defects
Posted April 22, 2011 on Carey & Danis Among all of the controversies surrounding the popular antidepressant medication Paxil, the most popular topics right now is whether Paxil really causes birth defects in children born to women who take Paxil during pregnancy. With so much research being conducted that shows Paxil’s risk to unborn babies Full Article…
Comments Off
Report: Drug makers paid $4.5B to settle legal issues in 2010
Posted December 23, 2010 on James Gallagher Boy, it was a rough year, legally speaking, for drug makers, particularly GlaxoSmithKline. According to the publication Fierce Pharma, pharmaceutical companies paid more than $4.5 billion to resolve legal issues ranging from off-label marketing investigations to price-fraud suits to liability litigation. And U.K.-based GSK (NYSE: GSK) ponied up Full Article…
Comments Off
Glaxo’s Legal Problems Lead to New $3.4 Billion Charge
Posted January 17, 2011 on NY Times The British drug maker GlaxoSmithKline announced Monday that it was setting aside $3.4 billion — wiping out fourth-quarter profit — to pay for United States government investigations and product liability cases over its marketing of the diabetes drug Avandia. The one-time charge is expected to exceed GlaxoSmithKline’s quarterly Full Article…
Comments Off
Whistleblower Alleges Problems with Paxil Doses
Posted January 9, 2011 by Heidi Turner Boston, MA: With some pregnant women concerned about Paxil side effects and what consequences potential Paxil birth defects could have on their infants, news that some Paxil shipments contained incorrect doses might be a cause for alarm. Although those shipments occurred in the past—they were recently discussed in Full Article…
Comments Off
New Hampshire Wins $1.24 Million Lawsuit Against Glaxo
Posted January 3, 2011 on Carey & Danis The state of New Hampshire has recently been awarded the sum of $1.7 million against GlaxosmithKline, the makers of the popular antidepressant drug Paxil. The lawsuit was brought against two prescription drug makers because the state claims that their Medicaid Program was billed for drugs like Paxil Full Article…
Comments Off
GSK responds to 60 Minutes
Posted January 3, 2011 on gsk.com GlaxoSmithKline [GSK] issued the following response regarding a 60 Minutes program on January 2 that focused on a manufacturing facility in Puerto Rico which was formerly owned by the company. GSK regrets the manufacturing issues at the Cidra facility, which were inconsistent with GSK’s commitment to manufacturing quality. It Full Article…
Comments Off
Glaxo Adulterated Drug Case May Continue
Posted November 7, 2010 on Carey & Danis The recent suit against GlaxoSmithKline, the makers of Paxil CR, that orders the company to pay $750 million in penalties to the federal government for selling adulterated drugs may not be over yet. The government plans to follow up on the poor manufacturing practices present at GSK’s Full Article…
Comments Off
Adulterated Drug Case Against Glaxo Settled
Posted November 17, 2010 on Carey & Danis GlaxoSmithKline, the manufacturer of the popular antidepressant drug Paxil, recently lost another case when the State of Washington was awarded $6 million for its case that claimed that Glaxo sold drugs that didn’t meet federal standards. Last month, court proceedings revealed that GSK made a mistake during Full Article…
Comments Off
Adulterated Drug Case Against Glaxo Settled
Posted November 17, 2010 by Carey & Danis GlaxoSmithKline, the manufacturer of the popular antidepressant drug Paxil, recently lost another case when the State of Washington was awarded $6 million for its case that claimed that Glaxo sold drugs that didn’t meet federal standards. Last month, court proceedings revealed that GSK made a mistake during Full Article…
Comments Off
